Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Massaia

Showing results (1-10 of 89) with videos related to

Pageof 9
Sort By:
Acta Oncologica (Stockholm, Sweden)|January 6, 2001
Idiotype vaccination of myeloma patients after chemotherapyM Massaia
Leukemia & Lymphoma|March 1, 1995
T cells in multiple myeloma: is this a reliable population to count on as antitumor effector cells?M Massaia, A Pileri
Molecular Medicine Today|November 14, 1997
Idiotypic vaccination in B-cell malignanciesA Bianchi, M Massaia
Current Pharmaceutical Design|August 21, 2010
Nitrogen-containing bisphosphonates and cancer immunotherapyP Clézardin, M Massaia
Journal of Clinical & Laboratory Immunology|February 1, 1984
Soluble factor(s) released by Concanavalin A activated lymph node lymphocytes induce proliferation and maturation of chronic lymphocytic leukaemia (CLL) B lymphocytesL Matera, M Massaia, L Pegoraro
Seminars in Hematology|February 16, 1999
Idiotypic vaccination as therapy for multiple myelomaL W Kwak, K Thielemans, M Massaia
Minerva Medica|April 28, 1982
[Idiotypic study of human myeloma]M Boccadoro, P Gavarotti, M Massaia, et al.
Haematologica|March 1, 1987
Multiple myeloma: biological and clinical significance of bone marrow plasma cell labelling indexM Boccadoro, M Massaia, U Dianzani, et al.
Recenti Progressi in Medicina|November 7, 2001
[PSA/volume ratio in prostatic disease in the elderly]M Bo, M Ventura, M Massaia, et al.
Clinical and Experimental Immunology|January 1, 1983
The idiotypic specificities of lymphocytes in human monoclonal gammopathies: analysis with the fluorescence activated cell sorterA L Carmagnola, M Boccadoro, M Massaia, et al.
Pageof 9

Showing results (1-10 of 89) with videos related to

Sort By:
Pageof 9
Acta Oncologica (Stockholm, Sweden)|January 6, 2001
Idiotype vaccination of myeloma patients after chemotherapyM Massaia
Leukemia & Lymphoma|March 1, 1995
T cells in multiple myeloma: is this a reliable population to count on as antitumor effector cells?M Massaia, A Pileri
Molecular Medicine Today|November 14, 1997
Idiotypic vaccination in B-cell malignanciesA Bianchi, M Massaia
Current Pharmaceutical Design|August 21, 2010
Nitrogen-containing bisphosphonates and cancer immunotherapyP Clézardin, M Massaia
Journal of Clinical & Laboratory Immunology|February 1, 1984
Soluble factor(s) released by Concanavalin A activated lymph node lymphocytes induce proliferation and maturation of chronic lymphocytic leukaemia (CLL) B lymphocytesL Matera, M Massaia, L Pegoraro
Seminars in Hematology|February 16, 1999
Idiotypic vaccination as therapy for multiple myelomaL W Kwak, K Thielemans, M Massaia
Minerva Medica|April 28, 1982
[Idiotypic study of human myeloma]M Boccadoro, P Gavarotti, M Massaia, et al.
Haematologica|March 1, 1987
Multiple myeloma: biological and clinical significance of bone marrow plasma cell labelling indexM Boccadoro, M Massaia, U Dianzani, et al.
Recenti Progressi in Medicina|November 7, 2001
[PSA/volume ratio in prostatic disease in the elderly]M Bo, M Ventura, M Massaia, et al.
Clinical and Experimental Immunology|January 1, 1983
The idiotypic specificities of lymphocytes in human monoclonal gammopathies: analysis with the fluorescence activated cell sorterA L Carmagnola, M Boccadoro, M Massaia, et al.
Pageof 9